MINNEAPOLIS - February 26, 2003 - Mitch Kanter, Ph.D., director of discovery for Cargill Health & Food Technologies (H&FT), will be a featured speaker at the SoyFoods Summit 2003, February 26-28 in Miami. Dr. Kanter will discuss the health benefits of soy isoflavones, particularly as they relate to bone health. He also will review other emerging science, as well as the recent GRAS determination of AdvantaSoy™ isoflavones.
“Preliminary evidence in the published scientific literature suggests that isoflavones may benefit health by relieving some menopausal symptoms and maintaining bone health,” said Dr. Kanter. “Additional research is underway on a number of fronts, specifically on bone health,” he added. A brief biography of Dr. Kanter follows release. H&FT has completed a self-GRAS determination of AdvantaSoy™ Clear™ as a source of concentrated soy isoflavones in a variety of foods, including beverages, nutrition bars, yogurt, meal replacements and confections. The GRAS determination was affirmed by an independent panel of experts. AdvantaSoy™ Clear™ isoflavones, available in concentrations up to 50 percent, also have improved solubility, taste and color compared to many other isoflavone products. “The GRAS determination represents a significant opportunity for the consumer food product industry,” Dr. Kanter affirmed. “Under conditions of intended use, AdvantaSoy™ Clear™ would provide 30 to 50 milligrams soy isoflavones per customary serving.”
Cargill's H&FT business is part of a larger Cargill initiative called Food System Design. As such, Health & Food Technologies works in concert with customers to produce ingredient breakthroughs and other food system solutions that result in appetizing, nutritious, and convenient consumer products.
MITCH KANTER, Ph.D.
Director of Discovery
Cargill Health and Food Technologies
Mitch Kanter is the Director of Discovery in the Cargill Health and Food Technologies business unit. In his role, Dr. Kanter seeks to find new technologies and new ingredients that Cargill can license, co-develop, or co-market with perspective companies, universities, or inventors. He also develops and initiates research protocols with external scientists on studies that serve to support claims for existing products, and that may lead to the development of new, proprietary products.
Kanter began his industrial career with Ross Laboratories in 1988, where he served as a Clinical Research Manager in charge of clinical trials designed to test the efficacy of various weight loss supplements. He later spent ten years with the Quaker Oats Company in Barrington, Illinois where he served in various capacities, including Director of the Gatorade Sports Science Institute, and Director of the Quaker Oats Health Institute. Prior to joining Cargill in 2000, Kanter served as the Director of Nutrition Science for the General Mills Company in Minneapolis, MN.
Kanter received his Bachelors degree in Health Education from Queens College in New York City, Master Degrees in Exercise Physiology and Nutrition (Queens College) and his Ph.D. in Physiology from The Ohio State University. Kanter also served as a Post Doctoral Research Fellow in the Department of Preventive Medicine at the Washington University School of Medicine in St. Louis. He is the author of numerous publications in scientific journals on areas ranging from Diet Modification, Health, and Exercise, to Antioxidants and Free Radical Production. Kanter has also served on the review boards of various scientific journals and organizations.
Cargill Health & Food Technologies, based in Minneapolis, is a leading developer, processor and marketer of science-based, healthy ingredients for food and dietary supplements worldwide. It is a business unit of Cargill, Incorporated, an international marketer, processor and distributor of agricultural, food, financial and industrial products and services with 97,000 employees in 59 countries. Cargill provides distinctive customer solutions in supply chain management, food applications, and health and nutrition.